Total Funding
4
70
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
143529
PeptiMed is a biopharmaceutical company that develops a potent siRNA molecule to down-regulate an oncogene target to treat cancer and more.
Nicholas Primiano: Founder and Chairman
Thomas Primiano: Chief Business Officer
About the Company
PeptiMed is a Wisconsin-based, seed-stage biopharmaceutical company that is developing a potent siRNA molecule to down-regulate an oncogene target to treat cancer, as well as a novel nanoparticle delivery system to enable its use in animals and humans. PeptiMed was founded by repeat biotech entrepreneurs with combined 100 years of academic and
corporate experience in cancer R&D.
